10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Total Liabilities : $19.80 Mil (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is 10X Capital Venture Acquisition III Total Liabilities?

10X Capital Venture Acquisition III's Total Liabilities for the quarter that ended in Sep. 2023 was $19.80 Mil.

10X Capital Venture Acquisition III's quarterly Total Liabilities increased from Mar. 2023 ($17.17 Mil) to Jun. 2023 ($18.43 Mil) and increased from Jun. 2023 ($18.43 Mil) to Sep. 2023 ($19.80 Mil).

10X Capital Venture Acquisition III's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.59 Mil) and increased from Dec. 2021 ($0.59 Mil) to Dec. 2022 ($283.59 Mil).

10X Capital Venture Acquisition III Total Liabilities Historical Data

The historical data trend for 10X Capital Venture Acquisition III's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10X Capital Venture Acquisition III Total Liabilities Chart

10X Capital Venture Acquisition III Annual Data

Trend

Dec21

Dec22

Total Liabilities

0.59

283.59

10X Capital Venture Acquisition III Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Liabilities	Get a 7-Day Free Trial						14.66	283.59	17.17	18.43	19.80

10X Capital Venture Acquisition III Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

10X Capital Venture Acquisition III's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	269.308	+	(0	+	3.0198066269804E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	14.28	+	0)
	=	283.59

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	308.855	-	25.267
	=	283.59

10X Capital Venture Acquisition III's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.524	+	(0	+	-1.7763568394003E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	14.28	+	0)
	=	19.80

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	43.995	-	24.191
	=	19.80

10X Capital Venture Acquisition III Total Liabilities Related Terms

Thank you for viewing the detailed overview of 10X Capital Venture Acquisition III's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » 10X Capital Venture Acquisition Corp III (AMEX:VCXBU) » Definitions » Total Liabilities

Comparable Companies

BCSA LCW GAQ FLME CHEA EVE HCMA SUAC ALCY HHLA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA

Traded in Other Exchanges

VCXB:USA

Address

1 World Trade Center, 85th Floor, New York, NY, USA, 10007

Website

https://www.10xspac.com

10X Capital Venture Acquisition Corp III is a blank check company.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Headlines

From GuruFocus

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

By GlobeNewswire • 08-10-2023